A collaboration of researchers from Kentucky, Missouri, and Ontario, Canada believe to have the answer: a new and effective dietary supplement ingredient called MHB3® Hyaluronan, a special hyaluronan biopolymer that is taken orally. Pre-clinical and clinical studies indicate MHB3® Hyaluronan is the first supplement ingredient actually proven to promote healthy cartilage and enhance joint function. The biomacromolecule hyaluronan is found throughout the body with high concentrations in synovial fluid and cartilage. With normal stress and aging, hyaluronan breaks down and deteriorates more rapidly than it can be restored. Baxyl's MHB3® Hyaluronan helps replenish the natural hyaluronan in the body which:
Unlike other joint supplement ingredients that use processed animal by-products, MHB3® Hyaluronan is microbially synthesized and has no Chinese origins.
The most critical difference between Baxyl's MHB3® Hyaluronan and other joint products is the controlled pre-clinical and clinical testing that confirms its bioavailability, safety, and efficacy.
In a human clinical trial of Baxyl, Douglas W. Kiburz MD, FAOOS, used the biopolymer orally with 50 subjects for one month. "I spend most of my professional time helping people deal with joint health. Because every patient has different needs, systemically supporting cartilage had tremendous appeal to me and my subjects," Dr. Kiburz said. "We conducted an open label study to assess its effectiveness with people. Over 80% of study participants reported good to excellent results." The physician continued, "With observations like that, MHB3® based products will make glucosamine and other joint supplements obsolete." The clinical trial also concluded that the use of MHB3® is safe, having produced no side effects, or apparent contraindications.